Evidence map›Paper›PMID 28484008›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells.

Bogdan Beirowski, Keit Men Wong, Elisabetta Babetto, Jeffrey Milbrandt

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Role of theBiomedicines · 2024
    Article
  12. TFEB/3 Govern Repair Schwann Cell Generation and Function Following Peripheral Nerve Injury.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bogdan BeirowskiHunter James Kelly Research Institute, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203; bogdanbe@buffalo.edu.ORCID 0000-0002-1241-1777
Keit Men WongHunter James Kelly Research Institute, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203.ORCID 0000-0002-5449-6318
Elisabetta BabettoHunter James Kelly Research Institute, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203.ORCID 0000-0002-6385-8288
Jeffrey MilbrandtDepartment of Genetics, Washington University School of Medicine in St. Louis, St. Louis, MO 63110.
University at Buffalo, State University of New York · USHarvard University Press · USWashington University in St. Louis · US

Funding

PHYSIOLOGY AND GENETICS OF THE GDNF HOMOLOG NEURTURINR01AG013730 · NIA · WASHINGTON UNIVERSITY · PI JEFFREY D MILBRANDT · 1996 to 2026
$10.6M
ROLE OF EGR2 MUTATIONS IN PERIPHERAL MYELINOPATHIESR01NS040745 · NINDS · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2001 to 2009
$3.3M
Regulating NAD Metabolism to Inhibit Axon Degeneration in Neurodegenerative DiseasesRF1AG013730 · NIA · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2017 to 2017
$2.8M
MOLECULAR CHARACTERIZATION OF NON-MYELINATING SCHWANN CELLSR21NS087306 · NINDS · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2014 to 2015
$554k
Compromised LDH activity causes motor deficits and hastens ALS progressionR56AG013730 · NIA · WASHINGTON UNIVERSITY · PI MILBRANDT, JEFFREY D · 2022 to 2022
$503k
NIA NIH HHS R01 AG013730NIA NIH HHS R56 AG013730NIA NIH HHS RF1 AG013730NINDS NIH HHS R01 NS040745NINDS NIH HHS R21 NS087306
6 · The paper itself

Abstract

The myelination of axons in peripheral nerves requires precisely coordinated proliferation and differentiation of Schwann cells (SCs). We found that the activity of the mechanistic target of rapamycin complex 1 (mTORC1), a key signaling hub for the regulation of cellular growth and proliferation, is progressively extinguished as SCs differentiate during nerve development. To study the effects of different levels of sustained mTORC1 hyperactivity in the SC lineage, we disrupted negative regulators of mTORC1, including TSC2 or TSC1, in developing SCs of mutant mice. Surprisingly, the phenotypes ranged from arrested myelination in nerve development to focal hypermyelination in adulthood, depending on the level and timing of mTORC1 hyperactivity. For example, mice lacking TSC2 in developing SCs displayed hyperproliferation of undifferentiated SCs incompatible with normal myelination. However, these defects and myelination could be rescued by pharmacological mTORC1 inhibition. The subsequent reconstitution of SC mTORC1 hyperactivity in adult animals resulted in focal hypermyelination. Together our data suggest a model in which high mTORC1 activity promotes proliferation of immature SCs and antagonizes SC differentiation during nerve development. Down-regulation of mTORC1 activity is required for terminal SC differentiation and subsequent initiation of myelination. In distinction to this developmental role, excessive SC mTORC1 activity stimulates myelin growth, even overgrowth, in adulthood. Thus, our work delineates two distinct functions of mTORC1 in the SC lineage essential for proper nerve development and myelination. Moreover, our studies show that SCs retain their plasticity to myelinate and remodel myelin via mTORC1 throughout life.

Indexed as

AnimalsAxonsCell Cycle CheckpointsCell LineCell PlasticityCell ProliferationGene DeletionMechanistic Target of Rapamycin Complex 1MiceMice, Inbred C57BLMice, KnockoutMyelin SheathSchwann CellsSirolimusTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 ProteinMechanistic Target of Rapamycin Complex 1SirolimusTsc1 protein, mouseTsc2 protein, mouseTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 ProteinTumor Suppressor Proteinsaxonmammalian target of rapamycinmyelinationneuropathyperipheral nerve

Identifiers

PMID28484008
PMCPMC5448230
OpenAlexW2612311034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.